Seattle Genetics, Inc. (SGEN): Price and Financial Metrics
Seattle Genetics, Inc. (SGEN)
Today's Latest Price: $162.59 USD
Updated Aug 5 8:00pm
Add SGEN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SGEN Stock Summary
- Seattle Genetics Inc's market capitalization of $28,721,622,063 is ahead of 93.35% of US-listed equities.
- SGEN's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 713.26 -- higher than 94.46% of US-listed equities with positive expected earnings growth.
- With a price/sales ratio of 28.28, Seattle Genetics Inc has a higher such ratio than 93.94% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Seattle Genetics Inc, a group of peers worth examining would be NVCN, STRO, FOLD, CLVS, and EDIT.
- Visit SGEN's SEC page to see the company's official filings. To visit the company's web site, go to www.seattlegenetics.com.
SGEN Stock Price Chart Technical Analysis Charts
SGEN Price/Volume Stats
| Current price | $162.59 | 52-week high | $187.99 |
| Prev. close | $165.07 | 52-week low | $65.44 |
| Day low | $162.13 | Volume | 908,400 |
| Day high | $165.96 | Avg. volume | 1,214,233 |
| 50-day MA | $165.74 | Dividend yield | N/A |
| 200-day MA | $130.99 | Market Cap | 28.29B |
Seattle Genetics, Inc. (SGEN) Company Bio
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. The company was founded in 1998 and is based in Bothell, Washington.
Loading social stream, please wait...